Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 2529 entries
View as:

A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT01576380 Org: User:
Start: 06/30/12 End: 09/30/13 Due: 09/30/14

Study of Efficacy of CDZ173 in Patients With APDS/PASLI

Phase: N/A Priority: Normal
NCT ID: NCT02435173 Org: User:
Start: 08/24/15 End: 08/16/21 Due: 08/16/22

Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction

Phase: N/A Priority: Normal
NCT ID: NCT02874794 Org: User:
Start: 08/17/16 End: 01/26/19 Due: 01/26/20

Efficacy of Diclofenac Potassium vs Nimesulide in the Treatment of Fever and Pain in Children With Upper Respiratory Tract Infection

Phase: N/A Priority: Normal
NCT ID: NCT01257126 Org: User:
Start: 04/30/11 End: - Due: -

A Study of the Clinical Safety, Tolerability, and Efficacy of Zoledronic Acid Compared to an Oral Bisphosphonate

Phase: N/A Priority: Normal
NCT ID: NCT00100555 Org: User:
Start: 06/30/04 End: 06/30/05 Due: 06/30/06

Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT00241111 Org: User:
Start: 09/30/03 End: - Due: -

Multiple Ascending Dose Study of MHS552 in Adults With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT05272059 Org: User:
Start: 09/01/23 End: 04/14/25 Due: 04/14/26

Study of Efficacy and Safety of MAS825 in Patients With COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04382651 Org: User:
Start: 06/11/20 End: 04/21/21 Due: 04/21/22

Evaluation of Exercise Treadmill Test (ETT) Indices in Participants With Cardiovascular Disease

Phase: N/A Priority: Normal
NCT ID: NCT01562041 Org: User:
Start: 03/09/12 End: 01/02/14 Due: 01/02/15

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VAY736 in Relapsed or Refractory CLL Patients

Phase: N/A Priority: Normal
NCT ID: NCT02137889 Org: User:
Start: 07/31/12 End: 11/30/12 Due: 11/30/13

A Study of mTOR Inhibitor Everolimus (RAD001) in Association With Cisplatin and Radiotherapy for Locally Advanced Cervix Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01217177 Org: User:
Start: 12/31/11 End: 04/30/14 Due: 04/30/15

Safety and Efficacy of Vildagliptin vs. Thiazolidinedione as add-on Therapy to Metformin in Patients With Type 2 Diabetes Not Controlled With Metformin Alone

Phase: N/A Priority: Normal
NCT ID: NCT00396227 Org: User:
Start: 10/31/06 End: - Due: -

A NIS of Alpelisib in Combination With Fulvestrant in Postmenopausal Women, and Men, With HR+,HER2- , Locally Advanced or Metastatic Breast Cancer With a PIK3CA Mutation, After Disease Progression Following Endocrine Therapy as Monotherapy, in the Real-world Setting

Phase: N/A Priority: Normal
NCT ID: NCT04967248 Org: User:
Start: 06/21/23 End: 10/18/24 Due: 10/18/25

Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

Phase: N/A Priority: Normal
NCT ID: NCT00968968 Org: User:
Start: 01/20/10 End: 03/30/18 Due: 03/30/19

A Phase III Study of and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines.

Phase: N/A Priority: Normal
NCT ID: NCT03580356 Org: User:
Start: 10/20/18 End: 06/14/22 Due: 06/14/23

AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01132612 Org: User:
Start: 05/11/10 End: 10/18/16 Due: 10/18/17

LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib

Phase: N/A Priority: Normal
NCT ID: NCT01828112 Org: User:
Start: 06/28/13 End: 11/10/23 Due: 11/10/24

Efficacy and Safety of the Switch From Sirolimus to Everolimus in Stable Maintenance Renal Transplant Patients Receiving a Calcineurin Inhibitor Free Regimen

Phase: N/A Priority: Normal
NCT ID: NCT00170820 Org: User:
Start: 02/28/05 End: - Due: -

Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin

Phase: N/A Priority: Normal
NCT ID: NCT01766778 Org: User:
Start: 05/13/13 End: 10/22/15 Due: 10/22/16

Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)

Phase: N/A Priority: Normal
NCT ID: NCT01327846 Org: User:
Start: 04/11/11 End: 04/14/19 Due: 04/14/20

LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01373086 Org: User:
Start: 05/31/11 End: 10/31/11 Due: 10/31/12

A Multicenter Study to Assess Response to Influenza Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab

Phase: N/A Priority: Normal
NCT ID: NCT04667117 Org: User:
Start: 01/14/21 End: 07/06/23 Due: 07/06/24

Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT01920477 Org: User:
Start: 08/13/13 End: 01/11/18 Due: 01/11/19

ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib

Phase: N/A Priority: Normal
NCT ID: NCT00272987 Org: User:
Start: 12/13/05 End: 10/21/19 Due: 10/21/20

Everolimus in de Novo Kidney Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT01410448 Org: User:
Start: 11/30/11 End: 12/31/15 Due: 12/31/16